ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Novel bioinformatics approaches for Rna analysis may reveal common promising molecular markers between three pediatric tumors (2021)
Silva, Andréa Martins da; Popolin Neto, Mário ; Paulovich, Fernando Vieira ; Salomão, Karina Bezerra; Silva, Keteryne Rodrigues da ; Veronez, Luciana Chain ; Silva Junior, Wilson Araújo da ; Valera, Elvis Terci; Scrideli, Carlos Alberto ; Tone, Luiz Gonzaga
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology - SIOP. Unidades: ICMC, FMRP, FCFRP
Assuntos: BIOINFORMÁTICA, APRENDIZADO COMPUTACIONAL, VISUALIZAÇÃO, BIOMARCADORES, NEOPLASIAS, MEDULOBLASTOMA, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Andréa Martins da et al. Novel bioinformatics approaches for Rna analysis may reveal common promising molecular markers between three pediatric tumors. Pediatric Blood and Cancer. Hoboken: Instituto de Ciências Matemáticas e de Computação, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.29349. Acesso em: 31 out. 2024. , 2021
APA
Silva, A. M. da, Popolin Neto, M., Paulovich, F. V., Salomão, K. B., Silva, K. R. da, Veronez, L. C., et al. (2021). Novel bioinformatics approaches for Rna analysis may reveal common promising molecular markers between three pediatric tumors. Pediatric Blood and Cancer. Hoboken: Instituto de Ciências Matemáticas e de Computação, Universidade de São Paulo. doi:10.1002/pbc.29349
NLM
Silva AM da, Popolin Neto M, Paulovich FV, Salomão KB, Silva KR da, Veronez LC, Silva Junior WA da, Valera ET, Scrideli CA, Tone LG. Novel bioinformatics approaches for Rna analysis may reveal common promising molecular markers between three pediatric tumors [Internet]. Pediatric Blood and Cancer. 2021 ; No 2021( S5): S541-542.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.29349
Vancouver
Silva AM da, Popolin Neto M, Paulovich FV, Salomão KB, Silva KR da, Veronez LC, Silva Junior WA da, Valera ET, Scrideli CA, Tone LG. Novel bioinformatics approaches for Rna analysis may reveal common promising molecular markers between three pediatric tumors [Internet]. Pediatric Blood and Cancer. 2021 ; No 2021( S5): S541-542.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.29349
Trabalho de evento-resumo periodico
Detection of IKZF1 deletions by a very simplified and low-cost reverse transcription polymerase chain reaction (RT-PCR) technique and ITS impact on childhood all prognosis (2017)
Moreira, L. B. P.; Queiróz, R. D. P.; Perna, E.; Suazo, V. K.; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Assuntos: LEUCEMIA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, L. B. P. et al. Detection of IKZF1 deletions by a very simplified and low-cost reverse transcription polymerase chain reaction (RT-PCR) technique and ITS impact on childhood all prognosis. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.26772. Acesso em: 31 out. 2024. , 2017
APA
Moreira, L. B. P., Queiróz, R. D. P., Perna, E., Suazo, V. K., Tone, L. G., & Scrideli, C. A. (2017). Detection of IKZF1 deletions by a very simplified and low-cost reverse transcription polymerase chain reaction (RT-PCR) technique and ITS impact on childhood all prognosis. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/pbc.26772
NLM
Moreira LBP, Queiróz RDP, Perna E, Suazo VK, Tone LG, Scrideli CA. Detection of IKZF1 deletions by a very simplified and low-cost reverse transcription polymerase chain reaction (RT-PCR) technique and ITS impact on childhood all prognosis [Internet]. Pediatric Blood and Cancer. 2017 ; 64 S188.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.26772
Vancouver
Moreira LBP, Queiróz RDP, Perna E, Suazo VK, Tone LG, Scrideli CA. Detection of IKZF1 deletions by a very simplified and low-cost reverse transcription polymerase chain reaction (RT-PCR) technique and ITS impact on childhood all prognosis [Internet]. Pediatric Blood and Cancer. 2017 ; 64 S188.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.26772
Trabalho de evento-resumo periodico
Overexpression of MIR‐483‐3P and MIR‐149‐3P is associated with clinical characteristics of pediatric adrenocortical tumors (2017)
Corrêa, C. A. P; Lira, R. C. P; Andrade, A. F; Yunes, J. A.; Brandalise, S. R.; Mastelllaro, M. J.; Leal, L. F.; Antonini, Sonir Roberto Rauber; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Fonte: Pediatric Blood and Cancer. Nome do evento: Annual Congresso of The International Society Of Paediatric Oncology (SIOP). Unidade: FMRP
Assuntos: ADRENORECEPTORES, TUMOR CARCINOIDE, NEOPLASIAS, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORRÊA, C. A. P et al. Overexpression of MIR‐483‐3P and MIR‐149‐3P is associated with clinical characteristics of pediatric adrenocortical tumors. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.26772. Acesso em: 31 out. 2024. , 2017
APA
Corrêa, C. A. P., Lira, R. C. P., Andrade, A. F., Yunes, J. A., Brandalise, S. R., Mastelllaro, M. J., et al. (2017). Overexpression of MIR‐483‐3P and MIR‐149‐3P is associated with clinical characteristics of pediatric adrenocortical tumors. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/pbc.26772
NLM
Corrêa CAP, Lira RCP, Andrade AF, Yunes JA, Brandalise SR, Mastelllaro MJ, Leal LF, Antonini SRR, Tone LG, Scrideli CA. Overexpression of MIR‐483‐3P and MIR‐149‐3P is associated with clinical characteristics of pediatric adrenocortical tumors [Internet]. Pediatric Blood and Cancer. 2017 ; no S295-S296.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.26772
Vancouver
Corrêa CAP, Lira RCP, Andrade AF, Yunes JA, Brandalise SR, Mastelllaro MJ, Leal LF, Antonini SRR, Tone LG, Scrideli CA. Overexpression of MIR‐483‐3P and MIR‐149‐3P is associated with clinical characteristics of pediatric adrenocortical tumors [Internet]. Pediatric Blood and Cancer. 2017 ; no S295-S296.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.26772
Trabalho de evento-resumo periodico
Impacts of HUWE1 knockdown in human hematopoietic stem cells with A KRAS (G12V) (2017)
Ruckert, M.; Brouwers-Vos, A.; Tone, Luiz Gonzaga; Schuringa, J. J.; Silveira, Vanessa da Silva
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Assuntos: MUTAÇÃO GENÉTICA, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUCKERT, M. et al. Impacts of HUWE1 knockdown in human hematopoietic stem cells with A KRAS (G12V). Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.26772. Acesso em: 31 out. 2024. , 2017
APA
Ruckert, M., Brouwers-Vos, A., Tone, L. G., Schuringa, J. J., & Silveira, V. da S. (2017). Impacts of HUWE1 knockdown in human hematopoietic stem cells with A KRAS (G12V). Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/pbc.26772
NLM
Ruckert M, Brouwers-Vos A, Tone LG, Schuringa JJ, Silveira V da S. Impacts of HUWE1 knockdown in human hematopoietic stem cells with A KRAS (G12V) [Internet]. Pediatric Blood and Cancer. 2017 ; 64 S201-S202.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.26772
Vancouver
Ruckert M, Brouwers-Vos A, Tone LG, Schuringa JJ, Silveira V da S. Impacts of HUWE1 knockdown in human hematopoietic stem cells with A KRAS (G12V) [Internet]. Pediatric Blood and Cancer. 2017 ; 64 S201-S202.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.26772
Trabalho de evento-resumo periodico
Investigation of RBM24 as a potential regulator of cellular proliferation, apoptosis and chemoresistance in medulloblastoma (2017)
Cruzeiro, G. Alencastro Veiga; Baroni, M.; Salomão, K. Bezerra; Lira, R. C. Peixoto; Geron, L.; Andrade, A. F.; Corrêa, C. Alves; Moreno, D. Antunes; Silveira, Vanessa da Silva; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Assuntos: MEDULOBLASTOMA, APOPTOSE, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZEIRO, G. Alencastro Veiga et al. Investigation of RBM24 as a potential regulator of cellular proliferation, apoptosis and chemoresistance in medulloblastoma. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.26772. Acesso em: 31 out. 2024. , 2017
APA
Cruzeiro, G. A. V., Baroni, M., Salomão, K. B., Lira, R. C. P., Geron, L., Andrade, A. F., et al. (2017). Investigation of RBM24 as a potential regulator of cellular proliferation, apoptosis and chemoresistance in medulloblastoma. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/pbc.26772
NLM
Cruzeiro GAV, Baroni M, Salomão KB, Lira RCP, Geron L, Andrade AF, Corrêa CA, Moreno DA, Silveira V da S, Scrideli CA, Tone LG. Investigation of RBM24 as a potential regulator of cellular proliferation, apoptosis and chemoresistance in medulloblastoma [Internet]. Pediatric Blood and Cancer. 2017 ; 64 S315.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.26772
Vancouver
Cruzeiro GAV, Baroni M, Salomão KB, Lira RCP, Geron L, Andrade AF, Corrêa CA, Moreno DA, Silveira V da S, Scrideli CA, Tone LG. Investigation of RBM24 as a potential regulator of cellular proliferation, apoptosis and chemoresistance in medulloblastoma [Internet]. Pediatric Blood and Cancer. 2017 ; 64 S315.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.26772
Trabalho de evento-resumo periodico
Differential expression of MST2 and MST4 among the molecular subgroups of medulloblastoma (2017)
Baroni, M.; Andrade, A. F.; Cruzeiro, G. A. V.; Correa, C. A. P.; Carlotti Júnior, Carlos Gilberto; Aguiar, S; Nunes, J. A.; Brandalise, S. R.; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Fonte: Pediatric Blood and Cancer. Nome do evento: Annual Congresso of The International Society Of Paediatric Oncology (SIOP). Unidade: FMRP
Assuntos: MEDULOBLASTOMA, EXPRESSÃO GÊNICA, SISTEMA NERVOSO CENTRAL, TUMOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARONI, M. et al. Differential expression of MST2 and MST4 among the molecular subgroups of medulloblastoma. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.26772. Acesso em: 31 out. 2024. , 2017
APA
Baroni, M., Andrade, A. F., Cruzeiro, G. A. V., Correa, C. A. P., Carlotti Júnior, C. G., Aguiar, S., et al. (2017). Differential expression of MST2 and MST4 among the molecular subgroups of medulloblastoma. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/pbc.26772
NLM
Baroni M, Andrade AF, Cruzeiro GAV, Correa CAP, Carlotti Júnior CG, Aguiar S, Nunes JA, Brandalise SR, Scrideli CA, Tone LG. Differential expression of MST2 and MST4 among the molecular subgroups of medulloblastoma [Internet]. Pediatric Blood and Cancer. 2017 ; no S315-S316.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.26772
Vancouver
Baroni M, Andrade AF, Cruzeiro GAV, Correa CAP, Carlotti Júnior CG, Aguiar S, Nunes JA, Brandalise SR, Scrideli CA, Tone LG. Differential expression of MST2 and MST4 among the molecular subgroups of medulloblastoma [Internet]. Pediatric Blood and Cancer. 2017 ; no S315-S316.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.26772
Trabalho de evento-resumo periodico
Effects of ubiquitin ligase HUWE1 on metabolic imbalances in leukemic cells (2017)
Ruckert, M.; Brouwers-Vos, A.; Tone, Luiz Gonzaga; Schuringa, J. J.; Silveira, Vanessa da Silva
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Assuntos: LEUCEMIA, CARCINOGÊNESE, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUCKERT, M. et al. Effects of ubiquitin ligase HUWE1 on metabolic imbalances in leukemic cells. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.26772. Acesso em: 31 out. 2024. , 2017
APA
Ruckert, M., Brouwers-Vos, A., Tone, L. G., Schuringa, J. J., & Silveira, V. da S. (2017). Effects of ubiquitin ligase HUWE1 on metabolic imbalances in leukemic cells. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/pbc.26772
NLM
Ruckert M, Brouwers-Vos A, Tone LG, Schuringa JJ, Silveira V da S. Effects of ubiquitin ligase HUWE1 on metabolic imbalances in leukemic cells [Internet]. Pediatric Blood and Cancer. 2017 ; 64 S187.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.26772
Vancouver
Ruckert M, Brouwers-Vos A, Tone LG, Schuringa JJ, Silveira V da S. Effects of ubiquitin ligase HUWE1 on metabolic imbalances in leukemic cells [Internet]. Pediatric Blood and Cancer. 2017 ; 64 S187.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.26772
Artigo de periodico-carta/editorial
MiR-708-5p is differentially expressed in childhood acute lymphoblastic leukemia but not strongly associated to clinical features. [Carta] (2015)
Oliveira, Jaqueline Carvalho de; Scrideli, Carlos Alberto; Brassesco, María Sol; Yunes, José Andres; Brandalise, Silvia Regina
Fonte: Pediatric Blood and Cancer. Unidade: FMRP
Assuntos: LEUCEMIA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Jaqueline Carvalho de et al. MiR-708-5p is differentially expressed in childhood acute lymphoblastic leukemia but not strongly associated to clinical features. [Carta]. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.25222. Acesso em: 31 out. 2024. , 2015
APA
Oliveira, J. C. de, Scrideli, C. A., Brassesco, M. S., Yunes, J. A., & Brandalise, S. R. (2015). MiR-708-5p is differentially expressed in childhood acute lymphoblastic leukemia but not strongly associated to clinical features. [Carta]. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/pbc.25222
NLM
Oliveira JC de, Scrideli CA, Brassesco MS, Yunes JA, Brandalise SR. MiR-708-5p is differentially expressed in childhood acute lymphoblastic leukemia but not strongly associated to clinical features. [Carta] [Internet]. Pediatric Blood and Cancer. 2015 ; 62( 1): 177-178.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.25222
Vancouver
Oliveira JC de, Scrideli CA, Brassesco MS, Yunes JA, Brandalise SR. MiR-708-5p is differentially expressed in childhood acute lymphoblastic leukemia but not strongly associated to clinical features. [Carta] [Internet]. Pediatric Blood and Cancer. 2015 ; 62( 1): 177-178.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.25222
Trabalho de evento-resumo periodico
Silencig of GDF15 gene and response to radiotherapy and the treatment with temozolomide in glioblastoma cell lines (2015)
Baroni, M.; Fedatto, P.; Andrade, A.; Suazo, V.; Queiróz, R.; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS CEREBRAIS, RADIOTERAPIA, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARONI, M. et al. Silencig of GDF15 gene and response to radiotherapy and the treatment with temozolomide in glioblastoma cell lines. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2015
APA
Baroni, M., Fedatto, P., Andrade, A., Suazo, V., Queiróz, R., Tone, L. G., & Scrideli, C. A. (2015). Silencig of GDF15 gene and response to radiotherapy and the treatment with temozolomide in glioblastoma cell lines. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Baroni M, Fedatto P, Andrade A, Suazo V, Queiróz R, Tone LG, Scrideli CA. Silencig of GDF15 gene and response to radiotherapy and the treatment with temozolomide in glioblastoma cell lines. Pediatric Blood and Cancer. 2015 ; 62 S283.[citado 2024 out. 31 ]
Vancouver
Baroni M, Fedatto P, Andrade A, Suazo V, Queiróz R, Tone LG, Scrideli CA. Silencig of GDF15 gene and response to radiotherapy and the treatment with temozolomide in glioblastoma cell lines. Pediatric Blood and Cancer. 2015 ; 62 S283.[citado 2024 out. 31 ]
Trabalho de evento-resumo periodico
Differential microRNAs expression profile in primary glioblastomas of children and adults, pilocytic astrocytomas and non-neoplastic white matter: identification of pathways involved in tumorigenesis (2015)
Darrigo Júnior, L. G.; Fedatto, P.; Silveira, Vanessa da Silva; Antonio, D. Marco; Valera, E.; Panepucci, R.; Goes, A.; Carlotti Júnior, Carlos Gilberto; Oliveira, R.; Neder, Luciano; Aguiar, S.; Yunes, J.; Brandalise, S.; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology. Unidade: FMRP
Assuntos: RNA, PEDIATRIA, NEOPLASIAS CEREBRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DARRIGO JÚNIOR, L. G. et al. Differential microRNAs expression profile in primary glioblastomas of children and adults, pilocytic astrocytomas and non-neoplastic white matter: identification of pathways involved in tumorigenesis. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2015
APA
Darrigo Júnior, L. G., Fedatto, P., Silveira, V. da S., Antonio, D. M., Valera, E., Panepucci, R., et al. (2015). Differential microRNAs expression profile in primary glioblastomas of children and adults, pilocytic astrocytomas and non-neoplastic white matter: identification of pathways involved in tumorigenesis. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Darrigo Júnior LG, Fedatto P, Silveira V da S, Antonio DM, Valera E, Panepucci R, Goes A, Carlotti Júnior CG, Oliveira R, Neder L, Aguiar S, Yunes J, Brandalise S, Tone LG, Scrideli CA. Differential microRNAs expression profile in primary glioblastomas of children and adults, pilocytic astrocytomas and non-neoplastic white matter: identification of pathways involved in tumorigenesis. Pediatric Blood and Cancer. 2015 ; 62 S183.[citado 2024 out. 31 ]
Vancouver
Darrigo Júnior LG, Fedatto P, Silveira V da S, Antonio DM, Valera E, Panepucci R, Goes A, Carlotti Júnior CG, Oliveira R, Neder L, Aguiar S, Yunes J, Brandalise S, Tone LG, Scrideli CA. Differential microRNAs expression profile in primary glioblastomas of children and adults, pilocytic astrocytomas and non-neoplastic white matter: identification of pathways involved in tumorigenesis. Pediatric Blood and Cancer. 2015 ; 62 S183.[citado 2024 out. 31 ]
Trabalho de evento-resumo periodico
microRNA signatures in pediatric adrenocortical tumors: identification of microRNAs and predicted pathways involved in tumorigenesis and prognosis (2015)
Fedatto, P.; Antonio, D. Marco; Baroni, M.; Panepucci, R.; Goes, A.; Martinelli Junior, Carlos Eduardo; Antonini, Sonir Roberto Rauber; Castro, Margaret de; Tucci Júnior, Silvio; Neder, Luciano; Seidinger, A.; Matellaro, M.; Yunes, J.; Brandalise, S.; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS DO CÓRTEX SUPRARRENAL, PEDIATRIA, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FEDATTO, P. et al. microRNA signatures in pediatric adrenocortical tumors: identification of microRNAs and predicted pathways involved in tumorigenesis and prognosis. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2015
APA
Fedatto, P., Antonio, D. M., Baroni, M., Panepucci, R., Goes, A., Martinelli Junior, C. E., et al. (2015). microRNA signatures in pediatric adrenocortical tumors: identification of microRNAs and predicted pathways involved in tumorigenesis and prognosis. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Fedatto P, Antonio DM, Baroni M, Panepucci R, Goes A, Martinelli Junior CE, Antonini SRR, Castro M de, Tucci Júnior S, Neder L, Seidinger A, Matellaro M, Yunes J, Brandalise S, Tone LG, Scrideli CA. microRNA signatures in pediatric adrenocortical tumors: identification of microRNAs and predicted pathways involved in tumorigenesis and prognosis. Pediatric Blood and Cancer. 2015 ; 62 S161.[citado 2024 out. 31 ]
Vancouver
Fedatto P, Antonio DM, Baroni M, Panepucci R, Goes A, Martinelli Junior CE, Antonini SRR, Castro M de, Tucci Júnior S, Neder L, Seidinger A, Matellaro M, Yunes J, Brandalise S, Tone LG, Scrideli CA. microRNA signatures in pediatric adrenocortical tumors: identification of microRNAs and predicted pathways involved in tumorigenesis and prognosis. Pediatric Blood and Cancer. 2015 ; 62 S161.[citado 2024 out. 31 ]
Trabalho de evento-resumo periodico
Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG) (2015)
Epelma, S.; Odone, V.; Gorender, E.; Medeiros, R. S. S.; Silva, L.
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FM
Assuntos: NEOPLASIAS DO SISTEMA NERVOSO, GLIOMA (TERAPIA;DIAGNÓSTICO), CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EPELMA, S. et al. Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG). Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/pbc.25715/epdf. Acesso em: 31 out. 2024. , 2015
APA
Epelma, S., Odone, V., Gorender, E., Medeiros, R. S. S., & Silva, L. (2015). Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG). Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1002/pbc.25715/epdf
NLM
Epelma S, Odone V, Gorender E, Medeiros RSS, Silva L. Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG) [Internet]. Pediatric Blood and Cancer. 2015 ; 62 S274.[citado 2024 out. 31 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pbc.25715/epdf
Vancouver
Epelma S, Odone V, Gorender E, Medeiros RSS, Silva L. Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG) [Internet]. Pediatric Blood and Cancer. 2015 ; 62 S274.[citado 2024 out. 31 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pbc.25715/epdf
Trabalho de evento-resumo periodico
microRNA expression in childhood acute lymphoblastic leukemia: identification of microRNAs involved in leukemogenesis and prognosis (2015)
Grecco, C.; Antonio, D. Marco; Oliveira, J.; Fedatto, P.; Panepucci, R.; Goes, A.; Silveira, A. B.; Yunes, J.; Brandalise, S.; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology. Unidade: FMRP
Assuntos: LEUCEMIA, EXPRESSÃO GÊNICA, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRECCO, C. et al. microRNA expression in childhood acute lymphoblastic leukemia: identification of microRNAs involved in leukemogenesis and prognosis. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2015
APA
Grecco, C., Antonio, D. M., Oliveira, J., Fedatto, P., Panepucci, R., Goes, A., et al. (2015). microRNA expression in childhood acute lymphoblastic leukemia: identification of microRNAs involved in leukemogenesis and prognosis. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Grecco C, Antonio DM, Oliveira J, Fedatto P, Panepucci R, Goes A, Silveira AB, Yunes J, Brandalise S, Tone LG, Scrideli CA. microRNA expression in childhood acute lymphoblastic leukemia: identification of microRNAs involved in leukemogenesis and prognosis. Pediatric Blood and Cancer. 2015 ; 62 S259.[citado 2024 out. 31 ]
Vancouver
Grecco C, Antonio DM, Oliveira J, Fedatto P, Panepucci R, Goes A, Silveira AB, Yunes J, Brandalise S, Tone LG, Scrideli CA. microRNA expression in childhood acute lymphoblastic leukemia: identification of microRNAs involved in leukemogenesis and prognosis. Pediatric Blood and Cancer. 2015 ; 62 S259.[citado 2024 out. 31 ]
Trabalho de evento-resumo periodico
Effect of the inhibition of the XPO7 gene in response to methylprednisolone in a corticoresistant T acute lymphoblastic leukemia cell line (2015)
Suazo, V.; Silveira, Vanessa da Silva; Andrade, A.; Queiróz, R.; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology. Unidade: FMRP
Assuntos: EXPRESSÃO GÊNICA, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SUAZO, V. et al. Effect of the inhibition of the XPO7 gene in response to methylprednisolone in a corticoresistant T acute lymphoblastic leukemia cell line. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2015
APA
Suazo, V., Silveira, V. da S., Andrade, A., Queiróz, R., Tone, L. G., & Scrideli, C. A. (2015). Effect of the inhibition of the XPO7 gene in response to methylprednisolone in a corticoresistant T acute lymphoblastic leukemia cell line. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Suazo V, Silveira V da S, Andrade A, Queiróz R, Tone LG, Scrideli CA. Effect of the inhibition of the XPO7 gene in response to methylprednisolone in a corticoresistant T acute lymphoblastic leukemia cell line. Pediatric Blood and Cancer. 2015 ; 62 S259.[citado 2024 out. 31 ]
Vancouver
Suazo V, Silveira V da S, Andrade A, Queiróz R, Tone LG, Scrideli CA. Effect of the inhibition of the XPO7 gene in response to methylprednisolone in a corticoresistant T acute lymphoblastic leukemia cell line. Pediatric Blood and Cancer. 2015 ; 62 S259.[citado 2024 out. 31 ]
Trabalho de evento-resumo periodico
Antitumor activity of AMG900 alone or in combination with histone deacetylase inhibitor SaHa on medulloblastoma cell lines (2014)
Geron, L.; Suazo, V. K.; Andrade, A. F.; Borges, K. S.; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Assuntos: MEDULOBLASTOMA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GERON, L. et al. Antitumor activity of AMG900 alone or in combination with histone deacetylase inhibitor SaHa on medulloblastoma cell lines. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2014
APA
Geron, L., Suazo, V. K., Andrade, A. F., Borges, K. S., Scrideli, C. A., & Tone, L. G. (2014). Antitumor activity of AMG900 alone or in combination with histone deacetylase inhibitor SaHa on medulloblastoma cell lines. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Geron L, Suazo VK, Andrade AF, Borges KS, Scrideli CA, Tone LG. Antitumor activity of AMG900 alone or in combination with histone deacetylase inhibitor SaHa on medulloblastoma cell lines. Pediatric Blood and Cancer. 2014 ; 61 S280.[citado 2024 out. 31 ]
Vancouver
Geron L, Suazo VK, Andrade AF, Borges KS, Scrideli CA, Tone LG. Antitumor activity of AMG900 alone or in combination with histone deacetylase inhibitor SaHa on medulloblastoma cell lines. Pediatric Blood and Cancer. 2014 ; 61 S280.[citado 2024 out. 31 ]
Trabalho de evento-resumo periodico
AMG 900, an aurora kinases inhibitor, enhances the chemosensitivity to topoisomerase II inhibitors and modulates gene expression in H295A adrenocortical tumor cell line (2014)
Scrideli, Carlos Alberto; Borges, K. S.; Andrade, A. F.; Silveira, V. S.; Antonio, D. A. Marco; Vasconcelos, E. J. R.; Antonini, Sonir Roberto Rauber; Martinelli Junior, Carlos Eduardo; Castro, Margaret de; Tone, Luiz Gonzaga
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Assuntos: NEOPLASIAS DO CÓRTEX SUPRARRENAL, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCRIDELI, Carlos Alberto et al. AMG 900, an aurora kinases inhibitor, enhances the chemosensitivity to topoisomerase II inhibitors and modulates gene expression in H295A adrenocortical tumor cell line. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2014
APA
Scrideli, C. A., Borges, K. S., Andrade, A. F., Silveira, V. S., Antonio, D. A. M., Vasconcelos, E. J. R., et al. (2014). AMG 900, an aurora kinases inhibitor, enhances the chemosensitivity to topoisomerase II inhibitors and modulates gene expression in H295A adrenocortical tumor cell line. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Scrideli CA, Borges KS, Andrade AF, Silveira VS, Antonio DAM, Vasconcelos EJR, Antonini SRR, Martinelli Junior CE, Castro M de, Tone LG. AMG 900, an aurora kinases inhibitor, enhances the chemosensitivity to topoisomerase II inhibitors and modulates gene expression in H295A adrenocortical tumor cell line. Pediatric Blood and Cancer. 2014 ; 61 S371.[citado 2024 out. 31 ]
Vancouver
Scrideli CA, Borges KS, Andrade AF, Silveira VS, Antonio DAM, Vasconcelos EJR, Antonini SRR, Martinelli Junior CE, Castro M de, Tone LG. AMG 900, an aurora kinases inhibitor, enhances the chemosensitivity to topoisomerase II inhibitors and modulates gene expression in H295A adrenocortical tumor cell line. Pediatric Blood and Cancer. 2014 ; 61 S371.[citado 2024 out. 31 ]
Trabalho de evento-resumo periodico
Effects of zebularine alone or in combination with the histone deacetylase inhibitor SAHA on medulloblastoma cells (2014)
Andrade, A. F.; Borges, K. S.; Suazo, V. K.; Castro-Gamero, A. M.; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Assuntos: MEDULOBLASTOMA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, A. F. et al. Effects of zebularine alone or in combination with the histone deacetylase inhibitor SAHA on medulloblastoma cells. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2014
APA
Andrade, A. F., Borges, K. S., Suazo, V. K., Castro-Gamero, A. M., Scrideli, C. A., & Tone, L. G. (2014). Effects of zebularine alone or in combination with the histone deacetylase inhibitor SAHA on medulloblastoma cells. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Andrade AF, Borges KS, Suazo VK, Castro-Gamero AM, Scrideli CA, Tone LG. Effects of zebularine alone or in combination with the histone deacetylase inhibitor SAHA on medulloblastoma cells. Pediatric Blood and Cancer. 2014 ; 61 S338.[citado 2024 out. 31 ]
Vancouver
Andrade AF, Borges KS, Suazo VK, Castro-Gamero AM, Scrideli CA, Tone LG. Effects of zebularine alone or in combination with the histone deacetylase inhibitor SAHA on medulloblastoma cells. Pediatric Blood and Cancer. 2014 ; 61 S338.[citado 2024 out. 31 ]
Trabalho de evento-resumo periodico
H1F1A is overexpressed in medulloblastomas and its inhibition is able in reduce proliferation and increase HIF2A and ATG16L1 methylation levels in a cell line model (2014)
Scrideli, Carlos Alberto; Cruzeiro, G. A. V.; Reis, M. B. F.; Eterovic, A. K.; Moreno, D. A.; Neder, Luciano; Oliveira, R. S.; Aguiar, S.; Yunes, J. A.; Brandalise, S. R.; Tone, Luiz Gonzaga; Valera, Elvis Terci
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Assuntos: MEDULOBLASTOMA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCRIDELI, Carlos Alberto et al. H1F1A is overexpressed in medulloblastomas and its inhibition is able in reduce proliferation and increase HIF2A and ATG16L1 methylation levels in a cell line model. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2014
APA
Scrideli, C. A., Cruzeiro, G. A. V., Reis, M. B. F., Eterovic, A. K., Moreno, D. A., Neder, L., et al. (2014). H1F1A is overexpressed in medulloblastomas and its inhibition is able in reduce proliferation and increase HIF2A and ATG16L1 methylation levels in a cell line model. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Scrideli CA, Cruzeiro GAV, Reis MBF, Eterovic AK, Moreno DA, Neder L, Oliveira RS, Aguiar S, Yunes JA, Brandalise SR, Tone LG, Valera ET. H1F1A is overexpressed in medulloblastomas and its inhibition is able in reduce proliferation and increase HIF2A and ATG16L1 methylation levels in a cell line model. Pediatric Blood and Cancer. 2014 ; 61 S286-S287.[citado 2024 out. 31 ]
Vancouver
Scrideli CA, Cruzeiro GAV, Reis MBF, Eterovic AK, Moreno DA, Neder L, Oliveira RS, Aguiar S, Yunes JA, Brandalise SR, Tone LG, Valera ET. H1F1A is overexpressed in medulloblastomas and its inhibition is able in reduce proliferation and increase HIF2A and ATG16L1 methylation levels in a cell line model. Pediatric Blood and Cancer. 2014 ; 61 S286-S287.[citado 2024 out. 31 ]
Artigo de periodico
Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT) (2014)
Leite, Fabíola A; Lira, Régia C. P; Fedatto, Paola F; Antonini, Sonir Roberto Rauber; Martinelli Junior, Carlos Eduardo; Castro, Margaret de; Neder, Luciano; Ramalho, Leandra Naíra Zambelli; Tucci Júnior, Silvio; Mastelaro, Maria J; Seidinger, Ana L; Cardinalli, Izilda A; Yunes, José A; Brandalise, Silvia R; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Fonte: Pediatric Blood and Cancer. Unidade: FMRP
Assuntos: NEOPLASIAS DO CÓRTEX SUPRARRENAL, CRIANÇAS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Fabíola A et al. Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT). Pediatric Blood and Cancer, v. 61, n. 11, p. 1940-1948, 2014Tradução . . Disponível em: https://doi.org/10.1002/pbc.25118. Acesso em: 31 out. 2024.
APA
Leite, F. A., Lira, R. C. P., Fedatto, P. F., Antonini, S. R. R., Martinelli Junior, C. E., Castro, M. de, et al. (2014). Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT). Pediatric Blood and Cancer, 61( 11), 1940-1948. doi:10.1002/pbc.25118
NLM
Leite FA, Lira RCP, Fedatto PF, Antonini SRR, Martinelli Junior CE, Castro M de, Neder L, Ramalho LNZ, Tucci Júnior S, Mastelaro MJ, Seidinger AL, Cardinalli IA, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT) [Internet]. Pediatric Blood and Cancer. 2014 ; 61( 11): 1940-1948.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.25118
Vancouver
Leite FA, Lira RCP, Fedatto PF, Antonini SRR, Martinelli Junior CE, Castro M de, Neder L, Ramalho LNZ, Tucci Júnior S, Mastelaro MJ, Seidinger AL, Cardinalli IA, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT) [Internet]. Pediatric Blood and Cancer. 2014 ; 61( 11): 1940-1948.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.25118
Trabalho de evento-resumo periodico
Prognostic impact of the expression profile of the hypoxia related genes CA9, CA12, HIF2A, SCL2A1 and VEGF in osteosarcoma and ewing sarcoma (2014)
Scrideli, Carlos Alberto; França, M.; Engel, E. E.; Queiroz, Rosane Gomes de Paula; Neder, Luciano; Suazo, V. K.; Mori, B. O.; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Assuntos: OSTEOSSARCOMA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCRIDELI, Carlos Alberto et al. Prognostic impact of the expression profile of the hypoxia related genes CA9, CA12, HIF2A, SCL2A1 and VEGF in osteosarcoma and ewing sarcoma. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2014
APA
Scrideli, C. A., França, M., Engel, E. E., Queiroz, R. G. de P., Neder, L., Suazo, V. K., et al. (2014). Prognostic impact of the expression profile of the hypoxia related genes CA9, CA12, HIF2A, SCL2A1 and VEGF in osteosarcoma and ewing sarcoma. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Scrideli CA, França M, Engel EE, Queiroz RG de P, Neder L, Suazo VK, Mori BO, Tone LG, Scrideli CA. Prognostic impact of the expression profile of the hypoxia related genes CA9, CA12, HIF2A, SCL2A1 and VEGF in osteosarcoma and ewing sarcoma. Pediatric Blood and Cancer. 2014 ; 61 S275-S276.[citado 2024 out. 31 ]
Vancouver
Scrideli CA, França M, Engel EE, Queiroz RG de P, Neder L, Suazo VK, Mori BO, Tone LG, Scrideli CA. Prognostic impact of the expression profile of the hypoxia related genes CA9, CA12, HIF2A, SCL2A1 and VEGF in osteosarcoma and ewing sarcoma. Pediatric Blood and Cancer. 2014 ; 61 S275-S276.[citado 2024 out. 31 ]

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Nome do evento

Indexado em

Afiliação dos autores externos não normalizada